All products sold by Peptide Lab are strictly for laboratory research purposes only
You may still be a candidate for the Fitish Microdosing program, a lower dose option for patients who want a gentler, cosmetic approach
Prior to any pharma M&A position, analysts should model at least two patent litigation scenarios for the acquired asset: a scenario where a key patent survives a PTAB challenge, and one where it does not
This amount is both significant and sustainable, particularly when paired with a balanced diet and regular exercise, making it more effective than many other weight loss treatments
Even so, for a non-pharma or non-biologics company to offer a product into a hot market like this one, and an injectable no less, it does not seem like a good idea